Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

A national registry to assess the value of cardiovascular magnetic resonance imaging after primary percutaneous coronary intervention pathway activation: a feasibility cohort study.

Harris JM, Brierley RC, Pufulete M, Bucciarelli-Ducci C, Stokes EA, Greenwood JP, Dorman SH, Anderson RA, Rogers CA, Wordsworth S, Berry S, Reeves BC.

Southampton (UK): NIHR Journals Library; 2019 Jul.

2.

Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK.

Stokes EA, Doble B, Pufulete M, Reeves BC, Bucciarelli-Ducci C, Dorman S, Greenwood JP, Anderson RA, Wordsworth S.

BMJ Open. 2019 Jul 11;9(7):e025700. doi: 10.1136/bmjopen-2018-025700.

3.

Feasibility of identifying important changes in care management resulting from cardiovascular magnetic resonance (CMR) using hospital episode data in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.

Pufulete M, Harris J, Dorman S, Cook L, Bucciarelli-Ducci C, Greenwood J, Anderson R, Brierley R, Reeves BC.

BMC Med Res Methodol. 2019 Jun 6;19(1):116. doi: 10.1186/s12874-019-0755-3.

4.

Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study).

Pufulete M, Harris J, Sterne JAC, Johnson TW, Lasserson D, Mumford A, Doble B, Wordsworth S, Benedetto U, Rogers CA, Loke Y, Pithara C, Redwood S, Reeves BC.

BMJ Open. 2019 Jun 4;9(6):e029388. doi: 10.1136/bmjopen-2019-029388.

5.

'Off pump' self-expanding injectable tissue valves (IPVR) versus 'on pump' conventional tissue valves (PVR) for replacement of the pulmonary valve: trial protocol for a randomised controlled trial (InVITe trial).

Heys R, Angelini G, Caputo M, Culliford L, Pufulete M, Reeves BC, Rogers CA, Stoica S, Parry A.

BMJ Open. 2019 Apr 2;9(4):e026221. doi: 10.1136/bmjopen-2018-026221.

6.

Microvascular dysfunction determines infarct characteristics in patients with reperfused ST-segment elevation myocardial infarction: The MICROcirculation in Acute Myocardial Infarction (MICRO-AMI) study.

McAlindon E, Pufulete M, Harris J, Lawton C, Johnson T, Strange J, Baumbach A, Bucciarelli-Ducci C.

PLoS One. 2018 Nov 13;13(11):e0203750. doi: 10.1371/journal.pone.0203750. eCollection 2018.

7.

Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study.

Doble B, Pufulete M, Harris JM, Johnson T, Lasserson D, Reeves BC, Wordsworth S.

Health Qual Life Outcomes. 2018 Sep 20;16(1):191. doi: 10.1186/s12955-018-1019-3. Review.

8.

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.

Pufulete M, Maishman R, Dabner L, Higgins JPT, Rogers CA, Dayer M, MacLeod J, Purdy S, Hollingworth W, Schou M, Anguita-Sanchez M, Karlström P, Shochat MK, McDonagh T, Nightingale AK, Reeves BC.

Syst Rev. 2018 Jul 31;7(1):112. doi: 10.1186/s13643-018-0776-8.

9.
10.

Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.

Pufulete M, Maishman R, Dabner L, Mohiuddin S, Hollingworth W, Rogers CA, Higgins J, Dayer M, Macleod J, Purdy S, McDonagh T, Nightingale A, Williams R, Reeves BC.

Health Technol Assess. 2017 Aug;21(40):1-150. doi: 10.3310/hta21400.

11.

Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.

Pufulete M, Brierley RC, Bucciarelli-Ducci C, Greenwood JP, Dorman S, Anderson RA, Harris J, McAlindon E, Rogers CA, Reeves BC.

BMJ Open. 2017 Jun 22;7(6):e014627. doi: 10.1136/bmjopen-2016-014627. Review.

12.

Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.

Palmerini T, Della Riva D, Benedetto U, Bacchi Reggiani L, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Sangiorgi D, Biondi-Zoccai G, Généreux P, Angelini GD, Pufulete M, White J, Bhatt DL, Stone GW.

Eur Heart J. 2017 Apr 7;38(14):1034-1043. doi: 10.1093/eurheartj/ehw627. Review.

13.

Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure.

Mohiuddin S, Reeves B, Pufulete M, Maishman R, Dayer M, Macleod J, McDonagh T, Purdy S, Rogers C, Hollingworth W.

BMJ Open. 2016 Dec 28;6(12):e014010. doi: 10.1136/bmjopen-2016-014010.

14.

The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.

Hollingworth W, Biswas M, Maishman RL, Dayer MJ, McDonagh T, Purdy S, Reeves BC, Rogers CA, Williams R, Pufulete M.

Int J Cardiol. 2016 Dec 1;224:132-138. doi: 10.1016/j.ijcard.2016.09.021. Epub 2016 Sep 15.

PMID:
27648982
15.

Pre-admission interventions to improve outcome after elective surgery-protocol for a systematic review.

Perry R, Scott LJ, Richards A, Haase AM, Savović J, Ness AR, Atkinson C, Harris J, Culliford L, Shah S, Pufulete M.

Syst Rev. 2016 May 23;5:88. doi: 10.1186/s13643-016-0266-9.

16.

Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.

McAlindon E, Pufulete M, Lawton C, Angelini GD, Bucciarelli-Ducci C.

Eur Heart J Cardiovasc Imaging. 2015 Jul;16(7):738-46. doi: 10.1093/ehjci/jev001. Epub 2015 Mar 2.

17.

Measurement of myocardium at risk with cardiovascular MR: comparison of techniques for edema imaging.

McAlindon EJ, Pufulete M, Harris JM, Lawton CB, Moon JC, Manghat N, Hamilton MC, Weale PJ, Bucciarelli-Ducci C.

Radiology. 2015 Apr;275(1):61-70. doi: 10.1148/radiol.14131980. Epub 2014 Oct 21.

PMID:
25333474
18.

Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure.

Pufulete M, Higgins JP, Rogers CA, Dreyer L, Hollingworth W, Dayer M, Nightingale A, McDonagh T, Reeves BC.

Syst Rev. 2014 May 2;3:41. doi: 10.1186/2046-4053-3-41.

19.

The association between MTHFR 677C>T genotype and folate status and genomic and gene-specific DNA methylation in the colon of individuals without colorectal neoplasia.

Hanks J, Ayed I, Kukreja N, Rogers C, Harris J, Gheorghiu A, Liu CL, Emery P, Pufulete M.

Am J Clin Nutr. 2013 Dec;98(6):1564-74. doi: 10.3945/ajcn.113.061432. Epub 2013 Oct 9.

20.

The influence of folate supplementation on global gene expression in normal colonic mucosa of subjects with colorectal adenoma.

Pufulete M, Abbadi RA, Arno M, Ewins M, Green C, Astarloa EA, Sanders T, Emery P.

Mol Nutr Food Res. 2013 Apr;57(4):709-20. doi: 10.1002/mnfr.201200617. Epub 2013 Jan 24.

PMID:
23554054
21.

Short-term folate supplementation in physiological doses has no effect on ESR1 and MLH1 methylation in colonic mucosa of individuals with adenoma.

Al-Ghnaniem Abbadi R, Emery P, Pufulete M.

J Nutrigenet Nutrigenomics. 2012;5(6):327-38. doi: 10.1159/000345819. Epub 2013 Jan 16.

22.

Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review.

Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J.

Am J Epidemiol. 2009 Nov 15;170(10):1207-21. doi: 10.1093/aje/kwp275. Epub 2009 Oct 21. Review.

23.

Folate status of Ghanaian populations in London and Accra.

Owusu M, Thomas J, Wiredu E, Pufulete M.

Br J Nutr. 2010 Feb;103(3):437-44. doi: 10.1017/S0007114509991838. Epub 2009 Oct 14.

PMID:
19825217
24.

The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors.

Ally MS, Al-Ghnaniem R, Pufulete M.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):922-8. doi: 10.1158/1055-9965.EPI-08-0703. Epub 2009 Mar 3.

25.

Intake of dairy products and risk of colorectal neoplasia.

Pufulete M.

Nutr Res Rev. 2008 Jun;21(1):56-67. doi: 10.1017/S0954422408035920. Review.

PMID:
19079854
26.

Factors associated with knowledge of genetics and nutritional genomics among dietitians.

McCarthy S, Pufulete M, Whelan K.

J Hum Nutr Diet. 2008 Dec;21(6):547-54. doi: 10.1111/j.1365-277X.2008.00913.x. Epub 2008 Aug 27.

PMID:
18759954
27.
28.

Genetics and diet--gene interactions: involvement, confidence and knowledge of dietitians.

Whelan K, McCarthy S, Pufulete M.

Br J Nutr. 2008 Jan;99(1):23-8. Epub 2007 Aug 13.

PMID:
17692149
29.

Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma.

Pufulete M, Al-Ghnaniem R, Khushal A, Appleby P, Harris N, Gout S, Emery PW, Sanders TA.

Gut. 2005 May;54(5):648-53.

30.

Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer.

Pufulete M, Al-Ghnaniem R, Rennie JA, Appleby P, Harris N, Gout S, Emery PW, Sanders TA.

Br J Cancer. 2005 Mar 14;92(5):838-42.

31.

Approaches to carcinogenic risk assessment for polycyclic aromatic hydrocarbons: a UK perspective.

Pufulete M, Battershill J, Boobis A, Fielder R.

Regul Toxicol Pharmacol. 2004 Aug;40(1):54-66.

PMID:
15265606
32.

Folate, DNA methylation and colo-rectal cancer.

Pufulete M, Emery PW, Sanders TA.

Proc Nutr Soc. 2003 May;62(2):437-45. Review.

PMID:
14506892
33.

Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study.

Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, Emery PW, Sanders TA.

Gastroenterology. 2003 May;124(5):1240-8.

PMID:
12730865
34.

Validation of a short food frequency questionnaire to assess folate intake.

Pufulete M, Emery PW, Nelson M, Sanders TA.

Br J Nutr. 2002 Apr;87(4):383-90.

PMID:
12064348

Supplemental Content

Loading ...
Support Center